BG28413A3 - Method of obtaining of n- substituated lactams - Google Patents

Method of obtaining of n- substituated lactams

Info

Publication number
BG28413A3
BG28413A3 BG7737618A BG3761877A BG28413A3 BG 28413 A3 BG28413 A3 BG 28413A3 BG 7737618 A BG7737618 A BG 7737618A BG 3761877 A BG3761877 A BG 3761877A BG 28413 A3 BG28413 A3 BG 28413A3
Authority
BG
Bulgaria
Prior art keywords
substituated
lactams
obtaining
substituated lactams
Prior art date
Application number
BG7737618A
Other languages
Bulgarian (bg)
English (en)
Inventor
Ludovic
Lucien
Original Assignee
Ucb S.A.,Be
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb S.A.,Be filed Critical Ucb S.A.,Be
Publication of BG28413A3 publication Critical patent/BG28413A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
BG7737618A 1976-10-22 1977-10-19 Method of obtaining of n- substituated lactams BG28413A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB43934/76A GB1539817A (en) 1976-10-22 1976-10-22 N-substituted lactams

Publications (1)

Publication Number Publication Date
BG28413A3 true BG28413A3 (en) 1980-04-15

Family

ID=10431009

Family Applications (1)

Application Number Title Priority Date Filing Date
BG7737618A BG28413A3 (en) 1976-10-22 1977-10-19 Method of obtaining of n- substituated lactams

Country Status (27)

Country Link
US (1) US4162325A (de)
JP (1) JPS5839148B2 (de)
AT (1) AT352742B (de)
BE (1) BE859925A (de)
BG (1) BG28413A3 (de)
CA (1) CA1095040A (de)
CH (1) CH625214A5 (de)
CS (1) CS200231B2 (de)
CY (1) CY1037A (de)
DD (1) DD131930A5 (de)
DE (1) DE2747369A1 (de)
DK (1) DK461877A (de)
ES (1) ES463424A1 (de)
FI (1) FI66600C (de)
FR (1) FR2368474B1 (de)
GB (1) GB1539817A (de)
HK (1) HK2380A (de)
HU (1) HU174864B (de)
IL (1) IL53171A (de)
KE (1) KE3013A (de)
MY (1) MY8000264A (de)
NL (1) NL7711414A (de)
PL (1) PL110679B1 (de)
SE (1) SE425782B (de)
SU (2) SU805945A3 (de)
YU (1) YU251977A (de)
ZA (1) ZA776260B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2960194D1 (en) * 1978-05-08 1981-04-16 Ucb Sa Lactam-n-acetic acids, their amides, process for their preparation and therapeutic compositions containing them
EP0115473A3 (de) * 1983-01-27 1987-01-21 Ciba-Geigy Ag Substituierte Pyrrolidinonderivate und Verfahren zu ihrer Herstellung
EP0115472A3 (de) * 1983-01-27 1985-10-02 Ciba-Geigy Ag Pyrrolidinonderivate und Verfahren zu ihrer Herstellung
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
EP0419683A4 (en) * 1989-04-13 1992-03-11 Japan Tobacco Inc. New amino acid derivatives having prolylendopeptidase inhibitor activity
US5206386A (en) * 1991-03-20 1993-04-27 Isp Investments Inc. Controlled release N-substituted pyrrolidone esters and process for the use thereof
DE4308034A1 (de) * 1993-03-13 1994-09-15 Cassella Ag Neue Heterocyclen, ihre Herstellung und ihre Verwendung
US5658940A (en) * 1995-10-06 1997-08-19 Celgene Corporation Succinimide and maleimide cytokine inhibitors
US5914332A (en) * 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
CN114685342B (zh) * 2020-12-25 2024-05-10 长沙博源医疗科技有限公司 一种左乙拉西坦衍生物、免疫原、抗左乙拉西坦特异性抗体及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121723A (en) * 1955-11-02 1964-02-18 Sterling Drug Inc Lower alkyl n-(tertiary-amino-lower-alkyl) lower alkamates and quaternary ammonium salts thereof
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
NL7407140A (nl) * 1974-03-07 1975-09-09 Jose Maria Espinos Taya En Jos Werkwijze voor de bereiding van een n-gesub- stitueerd pyrrolidon.
AT360980B (de) * 1976-01-14 1981-02-10 Pliva Pharm & Chem Works Verfahren zur herstellung von n-alkylamiden des 2-oxo-1-pyrrolidins

Also Published As

Publication number Publication date
HK2380A (en) 1980-01-25
DD131930A5 (de) 1978-08-09
DE2747369C2 (de) 1987-11-12
SU937450A1 (ru) 1982-06-23
SE425782B (sv) 1982-11-08
JPS5353649A (en) 1978-05-16
FI66600C (fi) 1984-11-12
IL53171A0 (en) 1977-12-30
DE2747369A1 (de) 1978-04-27
FR2368474A1 (de) 1978-05-19
NL7711414A (nl) 1978-04-25
FR2368474B1 (fr) 1980-08-08
DK461877A (da) 1978-04-23
FI773069A (fi) 1978-04-23
HU174864B (hu) 1980-03-28
AT352742B (de) 1979-10-10
ES463424A1 (es) 1978-07-16
CA1095040A (en) 1981-02-03
MY8000264A (en) 1980-12-31
ATA749677A (de) 1979-03-15
PL201601A1 (pl) 1979-01-29
CY1037A (en) 1980-08-01
CS200231B2 (en) 1980-08-29
ZA776260B (en) 1978-07-26
JPS5839148B2 (ja) 1983-08-27
GB1539817A (en) 1979-02-07
FI66600B (fi) 1984-07-31
US4162325A (en) 1979-07-24
KE3013A (en) 1980-02-01
BE859925A (fr) 1978-04-20
IL53171A (en) 1982-02-28
PL110679B1 (en) 1980-07-31
CH625214A5 (de) 1981-09-15
YU251977A (en) 1983-01-21
SE7711667L (sv) 1978-04-23
SU805945A3 (ru) 1981-02-15

Similar Documents

Publication Publication Date Title
BG28052A4 (en) Method of obtaining of aminoalkyl-heterocycles
BG28061A3 (en) Method of obtaining of hexahydrodibenzopyranones
BG33153A3 (en) Method for obtaining of 1- aryloxy- 2- hydroxy- 3- alkylene
JPS5340889A (en) Method of forming connecting leads
BG27734A3 (en) Method of obtaining of m- aryloxybenzaldehydes
BG28068A3 (en) Method of obtaining of 3-chlorcephalosporines
BG28849A3 (en) Method of obtaining of gamapyrons
BG28071A3 (en) Method of obtaining of 2-deoxystreptamineaminoglucosides
BG28072A4 (en) Method of obtaining of 1-substitvated canamyzine derivatives
BG27754A3 (en) Method of obtaining of 3- halomethylcephems
BG28413A3 (en) Method of obtaining of n- substituated lactams
BG28845A3 (en) Method of obtaining of n- alkyldiphenylamines
BG28055A3 (en) Method of obtaining of phenylperazine derivatives
BG28414A4 (en) Method of obtaining of 1- hydroxytetramydrobenzo (c) hinolines
BG28066A3 (en) Method of obtaining of pyridobenzodiazepinones
BG27755A3 (en) Method of obtaining of 7- alkoxy- 3- chlormethilcephems
BG28417A3 (en) Method of obtaining of trans- 5a- aryldecahydrobenzazepine
BG31074A3 (en) Method for obtaining of 1- oxadethiacefalosporine
BG31363A3 (en) Method for obtaining of haloacetamid
JPS52121933A (en) Method of embanking
JPS5332900A (en) Method of synthetizing etrinjaite
JPS5358596A (en) Method of making polyallylpolyamines
JPS52120269A (en) Method of forming
JPS52108937A (en) Method of polybrominating bissphenoxyalkane
JPS5377090A (en) Method of etherizing